CNBP technology targets chronic pain

cnbplogosquare117 May 2016:

A consortium led by Macquarie University, utilising technology established by the ARC Centre of Excellence for BioPhotonics (CNBP), has been awarded a $340,000 Linkage Grant by the Australian Research Council, to target the debilitating effects of chronic pain.

The grant, bringing together researchers from Macquarie University, the University of Adelaide and the regenerative medicine company Regeneus, will support work that aims to relieve chronic pain in animals and will lay the foundations for future human therapies, using molecular tests, cell technologies and immune/hormonal pain generators.

According to Mark Hutchinson, Professor at the University of Adelaide and CNBP Director, the consortium’s activity will not only seek to target the incapacitating effects of chronic pain but will also aid understanding of how men and women feel pain differently.

To find out more you can view the CNBP media release, accessible online.

Image below: Immune cell responses within the central nervous system in response to chronic pain.

Immune cell responses_2